|
AU2004242546A1
|
|
Dosage formulations for acetylcholinesterase inhibitors
|
|
AU2003215227A1
|
|
Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
|
|
CA2393301A1
|
|
Analogs of galanthamine and lycoramine as modulators of nicotinic receptors
|
|
CA2354035A1
|
|
Use of acetylcholinesterase inhibitors on the modulation of the hypothalamic-pituitary-gonadal axis
|
|
WO0030446A1
|
|
Dosage formulations for acetylcholinesterase inhibitors
|
|
AU2914495A
|
|
Method and medicine for alleviating jet lag
|
|
US6150354A
|
|
Compounds for the treatment of Alzheimer's disease
|
|
CA1326632C
|
|
Long-active drug formulations comprising galanthamine for treatment of alzheimer's disease
|
|
EP0363415A1
|
|
Compounds for the treatment of alzheimer's disease
|
|
US4663318A
|
|
Method of treating Alzheimer's disease
|
